Rajiv Kumar

Employment

• Banaras Hindu University Institute of Medical Sciences Assistant Professor
  2018 - Present
• Banaras Hindu University Faculty of Science INSPIRE Faculty
  2016 - 2018
• Netaji Subhas Institute of Technology Asst. Professor (INSPIRE Faculty)
  2015 - 2016
• National Institute of Technology Rourkela Asst. Professor (INSPIRE Faculty)
  2014 - 2015
• Banaras Hindu University Institute of Medical Sciences Scientist (NIH-TMRC Project)
  2011 - 2012

Education

• Banaras Hindu University Institute of Medical Sciences Ph.D
  2007 - 2011
• Banaras Hindu University M.Sc
  2004 - 2006

Projects & Funding

Projects & funding information is unavailable.

Publications (72)

• Green-Synthesized Silver Nanoparticles from Penicillium oxalicum with Antibreast Cancer Activities In Vitro and In Vivo
  ACS Applied Bio Materials 2026 DOI: 10.1021/acsabm.5c02359
  +Save
• A Trypanothione Synthetase-Based Subunit Vaccine Induces Protective Th1 Immunity against Visceral Leishmaniasis in Mice
  ACS Pharmacology & Translational Science 2026 DOI: 10.1021/acsptsci.6c00119
  +Save
• Phytochemical characterization and assessment of anti-leishmanial activity of Toona ciliata M. Roem leaf extract in Leishmania donovani infection
  RSC Advances 2026 DOI: 10.1039/D6RA01962E
  +Save
• Unveiling the molecular mechanisms of hemorrhagic shock and acute lung injury: An integrative RNA-Seq and network analysis
  Translational Research 2025 DOI: 10.1016/j.trsl.2025.10.002
  +Save
• Amine-Functionalized Graphene Quantum Dots Conjugated with Amphotericin B: Synthesis, Characterization, and In Vitro Evaluation for Visceral Leishmaniasis Treatment
  ACS Omega 2025 DOI: 10.1021/acsomega.5c00879
  +Save
• Deciphering the landscape of triple negative breast cancer from microenvironment dynamics and molecular insights to biomarker analysis and therapeutic modalities
  Medicinal Research Reviews 2025 DOI: 10.1002/med.22090
  +Save
• Anti-leishmanial therapies: overcoming current challenges with emerging therapies
  Expert Review of Anti-infective Therapy 2025 DOI: 10.1080/14787210.2024.2438627
  +Save
• The circulating plasma microRNA signature in human visceral leishmaniasis.
  mSphere 2025 DOI: 10.1128/msphere.00646-24
  +Save
• Advancing Treatment for Leishmaniasis: From Overcoming Challenges to Embracing Therapeutic Innovations
  ACS Infectious Diseases 2025 DOI: 10.1021/acsinfecdis.4c00693
  +Save
• Navigating the Roadblocks: Progress and Challenges in Cell‐Based Therapies for Human Immunodeficiency Virus
  Journal of Cellular Biochemistry 2025 DOI: 10.1002/jcb.30669
  +Save